Skip to main content

Table 1 Measures of cardiac function in rats with myocardial infarction who received treatment with endothelial progenitor cells

From: Application of peripheral-blood-derived endothelial progenitor cell for treating ischemia-reperfusion injury and infarction: a preclinical study in rat models

Time

Groups

EDD

ESD

FS

EF

Week 2

Control (n = 28)

7.01 ± 0.27

4.11 ± 0.17

46.41 ± 2.25

31.67 ± 2.94

 

EPCs (n = 28)

6.01 ± 0.19*

3.09 ± 0.18*

60.51 ± 2.17*

66.18 ± 2.16*

Week 4

Control (n = 28)

6.57 ± 0.28

3.66 ± 0.34

43.49 ± 3.07

35.37 ± 2.39

 

EPCs (n = 28)

5.69 ± 0.24*

2.64 ± 0.33*

56.48 ± 2.68*

68.39 ± 3.89*

  1. EPC, endothelial progenitor cell; EDD, end diastolic dimension; ESD, end systolic dimension; FS, fractional shortening; EF, ejection fraction.
  2. * Indicates a significant difference between the EPC and control group (P < 0.05).
Back to article page

Journal of Cardiothoracic Surgery

ISSN: 1749-8090

Contact us